A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Titel:
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Auteur:
Reutens, Anne T. Jandeleit-Dahm, Karin Thomas, Merlin Salim, Agus De Livera, Alysha M. Bach, Leon A. Colman, Peter G. Davis, Timothy M.E. Ekinci, Elif I. Fulcher, Greg Hamblin, Peter Shane Kotowicz, Mark A. MacIsaac, Richard J. Morbey, Claire Simmons, David Soldatos, Georgia Wittert, Gary Wu, Ted Cooper, Mark E. Shaw, Jonathan E.